NCT06702774
Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary completion date changed from estimate of Jan 31, 2025 to Jul 31, 2025 Show 5 more changesShow less
- Eligibility criteria expanded, about 4 words
- Trial completed
- Final enrollment: 43067 participants (planned 72000)
- Site details revised
- Publications: details revised at 1 of 1 entry
- Notable Trial status: Active, Not Recruiting to Recruiting
- Primary completion date: Oct 21, 2024 to Jan 31, 2025
- Study completion date: Mar 31, 2025 to Apr 30, 2025
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Prevalence rate of bacteriologically positive TB
Timeframe: In year 3 after recruitment
Secondary (3)
Prevalence rate of active TB
Notification rates of bacteriologically positive TB
Notification rates of active TB cases
Arms and interventions
InterventionExperimental
A single active case finding campaign for Tuberculosis will occur in Year 1 alongside the usual care.
ControlNo intervention
Usual care will be provided and no active case finding activities will be implemented.
Diagnostic tests: Active case finding
Sites
1 site in 1 country
- Guangxi Zhuang Autonomous Region Center for Disease Control and PreventionNanning, Guangxi, China